Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

The human papilloma vaccine: A time for NP leadership

Hardwicke, Robin L., PhD, RN, FNP-C, AACRN; Benjamins, Laura J., MD, MPH; Grimes, Richard M., PhD

doi: 10.1097/01.NPR.0000534943.29252.6f
Feature: IMMUNIZATIONS

Abstract: The human papilloma virus (HPV) causes approximately 30,700 annual cancer cases of the cervix, vulva, vagina, penis, oral cavity, and anus. Nurse practitioners can use their unique relationships with patients to advocate for the HPV vaccine. The purpose of this article is to update NPs on current knowledge regarding the HPV vaccine while providing appropriate information necessary for counseling patients and parents.

The human papilloma virus (HPV) causes approximately 30,700 annual cancer cases of the cervix, vulva, vagina, penis, oral cavity, and anus. Nurse practitioners can use their unique relationships with patients to advocate for the HPV vaccine. The purpose of this article is to update NPs on current knowledge regarding the HPV vaccine while providing appropriate information necessary for counseling patients and parents.

Robin L. Hardwicke is a professor of internal medicine and obstetrics/gynecology and reproductive medicine at the University of Texas Medical School at Houston, Houston, Tex.

Laura J. Benjamins is an associate professor at the Department of Pediatrics, Division of Adolescent Medicine Center for Clinical Research and Evidence Based Medicine, the University of Texas Health Science Center at Houston, Houston, Tex.

Richard M. Grimes is an adjunct professor at the Department of Internal Medicine, McGovern Medical School, University of Texas, Houston Health Science Center at Houston, Houston, Tex.

The authors have disclosed this manuscript was funded in part by the Baylor–UT Houston Center for AIDS Research Core Support Grant number AI36211 from the National Institute of Allergy and Infectious Diseases.

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.